MCID: SPN007
MIFTS: 31

Spinal Cord Oligodendroglioma

Categories: Bone diseases, Cancer diseases, Neuronal diseases

Aliases & Classifications for Spinal Cord Oligodendroglioma

MalaCards integrated aliases for Spinal Cord Oligodendroglioma:

Name: Spinal Cord Oligodendroglioma 12 15
Oligodendroglioma of Spinal Cord 12 71
Well Differentiated Spinal Cord Oligodendroglioma 12

Classifications:



External Ids:

Disease Ontology 12 DOID:3184
NCIt 49 C4535
UMLS 71 C0346295

Summaries for Spinal Cord Oligodendroglioma

MalaCards based summary : Spinal Cord Oligodendroglioma, also known as oligodendroglioma of spinal cord, is related to glioma and hydrocephalus. An important gene associated with Spinal Cord Oligodendroglioma is IDH1 (Isocitrate Dehydrogenase (NADP(+)) 1), and among its related pathways/superpathways are Neuroscience and Citrate cycle (TCA cycle). Affiliated tissues include spinal cord, breast and brain, and related phenotypes are cardiovascular system and nervous system

Related Diseases for Spinal Cord Oligodendroglioma

Diseases related to Spinal Cord Oligodendroglioma via text searches within MalaCards or GeneCards Suite gene sharing:

(showing 295, show less)
# Related Disease Score Top Affiliating Genes
1 glioma 30.5 TP53 NF1 IDH2 IDH1 FGFR1 EGFR
2 hydrocephalus 28.8 TP53 SYP GFAP FGFR1 ENO2
3 oligodendroglioma 26.6 TP53 SYP NF1 MGMT IDH2 IDH1
4 enchondroma 10.6 IDH2 IDH1
5 breast duct papilloma 10.5 IDH2 IDH1
6 cytogenetically normal acute myeloid leukemia 10.5 IDH2 IDH1
7 intracranial chondrosarcoma 10.5 IDH2 IDH1
8 periosteal chondrosarcoma 10.5 IDH2 IDH1
9 anaplastic oligodendroglioma 10.5 MGMT IDH2
10 juxtacortical chondroma 10.5 IDH2 IDH1
11 interval angle-closure glaucoma 10.5 IDH2 IDH1
12 clear cell chondrosarcoma 10.4 IDH2 IDH1
13 undifferentiated pleomorphic sarcoma 10.4 IDH2 IDH1
14 gastric neuroendocrine neoplasm 10.4 SYP ATRX
15 chondroblastic osteosarcoma 10.4 IDH2 IDH1
16 adult brain stem glioma 10.4 MGMT IDH2 IDH1
17 central nervous system rhabdomyosarcoma 10.4 MGMT IDH2 IDH1
18 acidophil adenoma 10.4 MGMT LGALS3
19 ovarian germ cell teratoma 10.4 SYP LGALS3
20 glioblastoma classical subtype 10.3 MGMT IDH1
21 rosette-forming glioneuronal tumor 10.3 SYP FGFR1
22 glomangiosarcoma 10.3 TP53 SYP
23 laryngeal neuroendocrine tumor 10.3 TP53 SYP
24 temporal lobe neoplasm 10.3 MGMT IDH1 ATRX
25 enchondromatosis, multiple, ollier type 10.3 IDH2 IDH1 ATRX
26 sarcomatoid transitional cell carcinoma 10.3 TP53 SYP
27 desmoplastic infantile ganglioglioma 10.3 SYP GFAP
28 lung combined type small cell carcinoma 10.3 SYP GFAP
29 lymphoepithelioma-like thymic carcinoma 10.3 SYP IDH1
30 biliary tract benign neoplasm 10.3 TP53 SYP
31 chiari malformation 10.3 SYP GFAP
32 posterior pituitary gland neoplasm 10.3 SYP GFAP
33 medullomyoblastoma 10.2 SYP GFAP
34 breast hemangioma 10.2 TP53 IDH2 IDH1
35 systemic mastocytosis 10.2 IDH2 IDH1 FGFR1
36 papillary squamous carcinoma 10.2 SYP EGFR
37 intraductal breast neoplasm 10.2 TP53 IDH2 IDH1
38 malignant melanocytic neoplasm of the peripheral nerve sheath 10.2 SYP ENO2
39 ureter small cell carcinoma 10.2 SYP ENO2
40 anal neuroendocrine tumor 10.2 SYP ENO2
41 papillary tumor of the pineal region 10.2 SYP ENO2
42 small cell carcinoma of the bladder 10.2 SYP ENO2
43 urinary bladder small cell neuroendocrine carcinoma 10.2 SYP ENO2
44 intracranial primitive neuroectodermal tumor 10.2 SYP ENO2
45 nodular prostate 10.2 SYP ENO2
46 appendix carcinoid tumor 10.2 SYP ENO2
47 binswanger's disease 10.2 SYP GFAP
48 auditory system cancer 10.2 SYP ENO2
49 anaplastic ependymoma 10.2 SYP GFAP
50 cloacogenic carcinoma 10.2 SYP ENO2
51 thymus small cell carcinoma 10.2 SYP ENO2
52 chordoid meningioma 10.2 SYP GFAP
53 mature teratoma of the ovary 10.2 SYP ENO2
54 extraosseous ewings sarcoma-primitive neuroepithelial tumor 10.2 SYP ENO2
55 duodenal benign neoplasm 10.2 SYP ENO2
56 ampulla of vater neoplasm 10.2 SYP ENO2
57 middle ear adenoma 10.2 SYP ENO2
58 nodular ganglioneuroblastoma 10.2 SYP ENO2
59 spinal cord astrocytoma 10.2 MGMT IDH1 GFAP
60 paratesticular lipoma 10.2 LAX1 ENO2
61 carotid body cancer 10.2 SYP ENO2
62 oligoastrocytoma 10.2 MGMT IDH2 GFAP
63 lipoma of spermatic cord 10.2 LAX1 ENO2
64 gastric small cell carcinoma 10.2 SYP ENO2
65 jejunal neoplasm 10.2 SYP ENO2
66 sensory organ benign neoplasm 10.2 SYP ENO2
67 cervical large cell neuroendocrine carcinoma 10.2 SYP ENO2
68 lung oat cell carcinoma 10.2 SYP ENO2
69 pineal parenchymal tumor of intermediate differentiation 10.2 SYP ENO2
70 cutaneous ganglioneuroma 10.2 SYP ENO2
71 endometrial small cell carcinoma 10.2 SYP ENO2
72 cervix small cell carcinoma 10.2 SYP ENO2
73 adrenal neuroblastoma 10.2 SYP ENO2
74 spinal cord glioma 10.1 IDH1 GFAP
75 extraventricular neurocytoma 10.1 SYP IDH1 GFAP
76 esophageal basaloid squamous cell carcinoma 10.1 TP53 EGFR
77 urethra transitional cell carcinoma 10.1 TP53 GFAP
78 esophagus verrucous carcinoma 10.1 TP53 EGFR
79 carcinoid tumors, intestinal 10.1 SYP ENO2
80 glomangiomatosis 10.1 TP53 SYP LAX1
81 angiocentric glioma 10.1 SYP IDH1 GFAP
82 tanycytic ependymoma 10.1 SYP IDH1 GFAP
83 papillary adenoma 10.1 TP53 SYP
84 gallbladder small cell carcinoma 10.1 SYP ENO2
85 localized chondrosarcoma 10.1 IDH2 FGFR1
86 colon neuroendocrine neoplasm 10.1 SYP ENO2
87 extraskeletal ewing sarcoma 10.1 SYP ENO2
88 carcinoid syndrome 10.1 SYP ENO2
89 soft tissue sarcoma 10.1 TP53 EGFR
90 bladder lateral wall cancer 10.1 SYP ENO2
91 nasal cavity olfactory neuroblastoma 10.1 SYP ENO2
92 breast malignant phyllodes tumor 10.1 TP53 EGFR
93 small intestine benign neoplasm 10.1 SYP ENO2
94 endobronchial lipoma 10.1 SYP ENO2
95 mediastinal cancer 10.1 SYP ENO2
96 sinonasal undifferentiated carcinoma 10.1 SYP IDH2 ENO2
97 paralytic lagophthalmos 10.1 NF1 LAX1
98 extraosseous ewing sarcoma 10.1 SYP ENO2
99 intracranial cysts 10.0 GFAP ENO2
100 gangliocytoma 10.0 SYP RBFOX3 GFAP
101 primitive neuroectodermal tumor of the cervix uteri 10.0 GFAP ENO2
102 adult oligodendroglioma 10.0 IDH2 IDH1 FGFR1 ATRX
103 spinal cord lipoma 10.0 MGMT LAX1 FGFR1 CYREN
104 rare tumor 10.0
105 primary peritoneal carcinoma 10.0 TP53 EGFR
106 adult astrocytic tumour 10.0 TP53 IDH2 IDH1 ATRX
107 askin's tumor 10.0 SYP ENO2
108 cerebral degeneration 10.0 SYP RBFOX3 GFAP
109 pituitary carcinoma 10.0 TP53 MGMT GFAP
110 cauda equina neoplasm 10.0 SYP RBFOX3 ENO2
111 cerebellar liponeurocytoma 10.0 SYP RBFOX3 ENO2
112 childhood pilocytic astrocytoma 10.0 NF1 IDH1
113 subleukemic leukemia 10.0 SYP RBFOX3 ENO2
114 skin squamous cell carcinoma 10.0 TP53 MGMT EGFR
115 keratinizing squamous cell carcinoma 10.0 TP53 SYP EGFR
116 chordoid glioma 10.0 TP53 SYP GFAP
117 dementia, lewy body 10.0 SYP RBFOX3 GFAP
118 extra-adrenal pheochromocytoma 10.0 SYP NF1
119 cerebellar astrocytoma 10.0 NF1 IDH2 IDH1
120 skin lipoma 9.9 NF1 FGFR1
121 pulmonary blastoma 9.9 TP53 SYP EGFR
122 polyp of corpus uteri 9.9 NF1 LGALS3
123 rete ovarii adenoma 9.9 NF1 LGALS3
124 adenosquamous carcinoma 9.9 TP53 SYP EGFR
125 rete ovarii neoplasm 9.9 NF1 LGALS3
126 focal cortical dysplasia, type ii 9.9 TP53 RBFOX3 GFAP
127 clear cell meningioma 9.9 SYP GFAP
128 pick disease of brain 9.9 SYP RBFOX3 GFAP
129 choriocarcinoma of ovary 9.9 TP53 ENO2
130 traumatic brain injury 9.9 GFAP ENO2
131 conventional fibrosarcoma 9.9 TP53 ENO2
132 extraosseous chondrosarcoma 9.9 SYP ENO2
133 obsolete: squamous cell carcinoma of head and neck 9.9 TP53 IDH2 EGFR
134 bile duct mucinous adenocarcinoma 9.9 TP53 SYP ENO2
135 myelofibrosis 9.9 TP53 IDH2 IDH1 FGFR1
136 prostate neuroendocrine neoplasm 9.9 TP53 SYP ENO2
137 granulosa cell tumor of the ovary 9.9 TP53 SYP ENO2
138 cystic basal cell carcinoma 9.9 SYP ENO2
139 rhabdoid cancer 9.9 TP53 SYP ENO2
140 glomus tumor 9.9 TP53 SYP ENO2
141 cell type benign neoplasm 9.9 TP53 SYP EGFR
142 ganglioneuroblastoma 9.9 TP53 SYP ENO2
143 ovarian serous cystadenocarcinoma 9.9 TP53 SYP EGFR
144 cerebral neuroblastoma 9.8 SYP GFAP ENO2
145 childhood oligodendroglioma 9.8 MGMT IDH2 IDH1 FGFR1 ATRX
146 cerebellopontine angle primitive neuroectodermal 9.8 SYP GFAP ENO2
147 thoracic benign neoplasm 9.8 TP53 IDH2 IDH1 EGFR
148 breast benign neoplasm 9.8 TP53 IDH2 IDH1 EGFR
149 papillary ependymoma 9.8 SYP GFAP ENO2
150 subependymoma 9.8 SYP GFAP ENO2
151 pineocytoma 9.8 SYP GFAP ENO2
152 breast carcinoma in situ 9.8 TP53 FGFR1 EGFR
153 vaginal endometrial stromal sarcoma 9.8 SYP GFAP ENO2
154 merkel cell carcinoma 9.8 TP53 SYP ENO2
155 endobronchial leiomyoma 9.8 SYP GFAP ENO2
156 rhabdomyosarcoma 2 9.8 TP53 SYP ENO2
157 rhabdoid meningioma 9.8 SYP GFAP ENO2
158 vagina sarcoma 9.8 SYP GFAP ENO2
159 dysembryoplastic neuroepithelial tumor 9.8 SYP IDH1 GFAP FGFR1
160 cerebellar medulloblastoma 9.8 SYP GFAP ENO2
161 olfactory nerve neoplasm 9.8 SYP GFAP ENO2
162 cranial nerve malignant neoplasm 9.8 SYP GFAP ENO2
163 pineal gland cancer 9.8 SYP GFAP ENO2
164 ependymoblastoma 9.8 SYP GFAP ENO2
165 bile duct adenocarcinoma 9.8 TP53 IDH2 IDH1 EGFR
166 melanotic neuroectodermal tumor 9.8 SYP GFAP ENO2
167 horseshoe kidney 9.8 SYP ENO2 EGFR
168 adrenal carcinoma 9.8 TP53 SYP ENO2
169 intrahepatic cholangiocarcinoma 9.8 TP53 IDH2 IDH1 EGFR
170 central neurocytoma 9.8 SYP GFAP ENO2
171 mesenchymal chondrosarcoma 9.8 SYP GFAP ENO2
172 subependymal giant cell astrocytoma 9.8 SYP GFAP ENO2
173 lumbosacral plexus lesion 9.8 SYP RBFOX3 NF1
174 granular cell tumor 9.8 SYP GFAP ENO2
175 tubular adenocarcinoma 9.8 SYP ENO2 EGFR
176 large cell neuroendocrine carcinoma 9.8 SYP ENO2 EGFR
177 chondrosarcoma, extraskeletal myxoid 9.8 SYP GFAP ENO2
178 ganglioneuroma 9.8 SYP GFAP ENO2
179 pacinian tumor 9.8 NF1 ENO2
180 adult malignant schwannoma 9.8 TP53 NF1
181 alveolar soft part sarcoma 9.8 SYP ENO2 EGFR
182 pelvic lipomatosis 9.8 SYP ENO2
183 malignant ependymoma 9.8 MGMT IDH1 GFAP EGFR
184 plexiform schwannoma 9.8 NF1 ENO2
185 testicular cancer 9.8 TP53 MGMT ENO2
186 salivary gland carcinoma 9.8 TP53 FGFR1 EGFR
187 wilms tumor predisposition 9.8 TP53 NF1
188 exophthalmos 9.8 SYP NF1 FGFR1
189 orbital cancer 9.8 NF1 ENO2
190 skin granular cell tumor 9.7 NF1 ENO2
191 choroid plexus cancer 9.7 TP53 SYP GFAP ATRX
192 corpus callosum lipoma 9.7 NF1 FGFR1
193 atypical teratoid rhabdoid tumor 9.7 TP53 SYP GFAP ATRX
194 cardiovascular cancer 9.7 TP53 SYP NF1
195 hemangioma 9.7 TP53 SYP IDH1 ENO2
196 breast neuroendocrine neoplasm 9.7 SYP ENO2
197 cerebral hemisphere lipoma 9.7 NF1 FGFR1
198 multiple endocrine neoplasia, type i 9.7 SYP NF1 ATRX
199 astroblastoma 9.7 SYP IDH1 GFAP ENO2
200 supratentorial primitive neuroectodermal tumor 9.7 SYP IDH1 GFAP ENO2
201 spinal cord disease 9.7 SYP NF1 GFAP
202 gemistocytic astrocytoma 9.7 TP53 MGMT IDH2 IDH1 GFAP
203 bladder urothelial carcinoma 9.7 TP53 IDH1 FGFR1 EGFR
204 specific developmental disorder 9.7 RBFOX3 NF1 ATRX
205 optic nerve astrocytoma 9.6 SYP NF1 ENO2
206 pleomorphic xanthoastrocytoma 9.6 TP53 SYP MGMT IDH1 GFAP
207 autonomic nervous system benign neoplasm 9.6 SYP NF1 ENO2
208 peripheral nervous system benign neoplasm 9.6 SYP NF1 ENO2
209 cardiovascular organ benign neoplasm 9.6 SYP NF1 ENO2
210 malignant glioma 9.6 TP53 MGMT GFAP EGFR
211 cholangiocarcinoma 9.5 TP53 LGALS3 IDH2 IDH1 EGFR
212 large cell carcinoma 9.5 SYP FGFR1 ENO2 EGFR
213 bone squamous cell carcinoma 9.5 TP53 EGFR
214 cerebrovascular benign neoplasm 9.5 TP53 SYP GFAP ENO2
215 central nervous system primitive neuroectodermal neoplasm 9.5 TP53 SYP GFAP ENO2
216 papilloma of choroid plexus 9.5 TP53 SYP GFAP ENO2
217 basaloid squamous cell carcinoma 9.5 TP53 SYP ENO2 EGFR
218 respiratory system benign neoplasm 9.5 TP53 SYP ENO2 EGFR
219 cystic teratoma 9.5 TP53 SYP GFAP ENO2
220 teratoma 9.5 TP53 SYP GFAP ENO2
221 mixed cell type cancer 9.5 TP53 SYP ENO2 EGFR
222 rhabdomyosarcoma 9.5 TP53 SYP ENO2 EGFR
223 thymic carcinoma 9.5 TP53 SYP ENO2 EGFR
224 cowden syndrome 1 9.5 TP53 NF1 EGFR
225 cowden syndrome 9.5 TP53 NF1 EGFR
226 small cell carcinoma 9.5 TP53 SYP ENO2 EGFR
227 neurofibrosarcoma 9.5 TP53 NF1 ENO2
228 small cell cancer of the lung 9.5 TP53 SYP ENO2 EGFR
229 squamous cell carcinoma, head and neck 9.5 TP53 MGMT LGALS3 IDH2 EGFR
230 autonomic nervous system neoplasm 9.5 TP53 SYP ENO2 EGFR
231 connective tissue benign neoplasm 9.5 TP53 NF1 ENO2
232 thymoma 9.5 TP53 SYP ENO2 EGFR
233 hemangioblastoma 9.4 SYP GFAP ENO2 EGFR
234 optic nerve glioma 9.4 NF1 GFAP ENO2
235 wilms tumor 1 9.4 TP53 SYP ENO2 EGFR
236 basal cell carcinoma 9.4 TP53 SYP LGALS3 EGFR
237 leiomyosarcoma 9.4 TP53 NF1 ENO2
238 clear cell ependymoma 9.4 SYP RBFOX3 IDH1 GFAP ENO2
239 malignant peripheral nerve sheath tumor 9.4 TP53 NF1 EGFR
240 neurilemmoma 9.4 NF1 GFAP ENO2
241 gliomatosis cerebri 9.4 TP53 SYP IDH1 GFAP EGFR
242 myeloproliferative neoplasm 9.4 NF1 IDH1 FGFR1 EGFR
243 li-fraumeni syndrome 9.4 TP53 NF1 IDH1 EGFR
244 gastric adenocarcinoma 9.4 TP53 MGMT LGALS3 FGFR1 EGFR
245 melanoma, cutaneous malignant 1 9.4 TP53 NF1 MGMT EGFR
246 chordoma 9.3 TP53 LGALS3 IDH1 GFAP EGFR
247 neurofibroma 9.3 TP53 SYP NF1 EGFR
248 juvenile pilocytic astrocytoma 9.3 SYP NF1 MGMT IDH1 GFAP
249 lung benign neoplasm 9.3 TP53 SYP MGMT ENO2 EGFR
250 skeletal muscle cancer 9.3 TP53 SYP NF1 ENO2
251 muscle cancer 9.3 TP53 SYP NF1 ENO2
252 brain glioma 9.3 TP53 MGMT IDH2 IDH1 GFAP EGFR
253 endocrine organ benign neoplasm 9.3 TP53 SYP NF1 ENO2
254 cranial nerve neoplasm 9.2 SYP NF1 GFAP ENO2
255 obstructive hydrocephalus 9.2 SYP NF1 GFAP ENO2
256 nervous system cancer 9.2 TP53 NF1 MGMT IDH1 EGFR
257 infratentorial cancer 9.2 TP53 SYP MGMT IDH1 GFAP EGFR
258 gliofibroma 9.2 TP53 SYP NF1 IDH1 GFAP
259 myelodysplastic syndrome 9.2 TP53 NF1 MGMT IDH2 IDH1 ATRX
260 frontal lobe neoplasm 9.1 TP53 SYP MGMT IDH1 ENO2 EGFR
261 breast adenocarcinoma 9.1 TP53 SYP MGMT IDH1 ENO2 EGFR
262 spinal cancer 9.1 SYP NF1 IDH1 GFAP ENO2
263 paraganglioma 9.0 SYP NF1 IDH2 GFAP ENO2
264 suppression of tumorigenicity 12 9.0 TP53 SYP IDH1 FGFR1 ENO2 EGFR
265 pilomyxoid astrocytoma 9.0 SYP NF1 IDH1 GFAP FGFR1 ATRX
266 neuroma 8.9 NF1 MGMT GFAP FGFR1 ENO2
267 glioma susceptibility 1 8.9 TP53 MGMT IDH2 IDH1 GFAP FGFR1
268 ganglioglioma 8.9 TP53 SYP NF1 GFAP ENO2
269 leukemia, acute myeloid 8.9 TP53 NF1 IDH2 IDH1 FGFR1 EGFR
270 peripheral nervous system neoplasm 8.9 TP53 SYP NF1 ENO2 EGFR
271 tuberous sclerosis 8.9 TP53 SYP NF1 GFAP ENO2
272 lung cancer susceptibility 3 8.9 TP53 NF1 MGMT IDH1 FGFR1 EGFR
273 gastrointestinal stromal tumor 8.9 TP53 SYP NF1 ENO2 EGFR
274 muscular disease 8.8 TP53 SYP NF1 ENO2 EGFR
275 grade iii astrocytoma 8.7 TP53 MGMT LGALS3 IDH2 IDH1 GFAP
276 retinitis pigmentosa 8.7 TP53 RBFOX3 IDH2 GFAP FGFR1 EGFR
277 neural tube defects 8.7 TP53 SYP NF1 MGMT GFAP ENO2
278 benign ependymoma 8.6 SYP NF1 MGMT GFAP ENO2 EGFR
279 ewing sarcoma 8.6 TP53 SYP NF1 FGFR1 ENO2 EGFR
280 cerebellum cancer 8.5 TP53 SYP NF1 IDH2 IDH1 GFAP
281 brain stem glioma 8.5 TP53 NF1 MGMT IDH2 IDH1 FGFR1
282 cerebral ventricle cancer 8.5 TP53 SYP RBFOX3 MGMT IDH2 IDH1
283 fibrillary astrocytoma 8.4 TP53 NF1 MGMT IDH2 IDH1 GFAP
284 mixed glioma 8.4 TP53 NF1 MGMT IDH2 IDH1 GFAP
285 supratentorial cancer 8.3 TP53 SYP RBFOX3 MGMT IDH2 IDH1
286 central nervous system benign neoplasm 8.3 TP53 SYP RBFOX3 NF1 IDH2 IDH1
287 central nervous system cancer 8.2 TP53 SYP NF1 MGMT IDH2 IDH1
288 cerebrum cancer 8.1 TP53 SYP RBFOX3 MGMT IDH2 IDH1
289 brain cancer 7.9 TP53 SYP NF1 MGMT IDH2 IDH1
290 neuroblastoma 7.9 TP53 SYP NF1 GFAP FGFR1 ENO2
291 meningioma, familial 7.9 TP53 SYP NF1 MGMT IDH1 GFAP
292 giant cell glioblastoma 7.9 TP53 SYP NF1 MGMT IDH2 IDH1
293 glioblastoma multiforme 7.9 TP53 SYP NF1 MGMT IDH2 IDH1
294 medulloblastoma 7.8 TP53 SYP NF1 MGMT IDH1 GFAP
295 gliosarcoma 7.4 TP53 SYP NF1 MGMT IDH2 IDH1

Graphical network of the top 20 diseases related to Spinal Cord Oligodendroglioma:



Diseases related to Spinal Cord Oligodendroglioma

Symptoms & Phenotypes for Spinal Cord Oligodendroglioma

MGI Mouse Phenotypes related to Spinal Cord Oligodendroglioma:

45 (showing 4, show less)
# Description MGI Source Accession Score Top Affiliating Genes
1 cardiovascular system MP:0005385 9.91 ATRX CYREN EGFR FGFR1 GFAP IDH2
2 nervous system MP:0003631 9.65 ATRX EGFR ENO2 FGFR1 GFAP LGALS3
3 neoplasm MP:0002006 9.63 EGFR IDH2 LGALS3 MGMT NF1 TP53
4 respiratory system MP:0005388 9.17 EGFR ENO2 IDH1 LGALS3 MGMT NF1

Drugs & Therapeutics for Spinal Cord Oligodendroglioma

Search Clinical Trials , NIH Clinical Center for Spinal Cord Oligodendroglioma

Genetic Tests for Spinal Cord Oligodendroglioma

Anatomical Context for Spinal Cord Oligodendroglioma

MalaCards organs/tissues related to Spinal Cord Oligodendroglioma:

40
Spinal Cord, Breast, Brain, Lung, Bone, Skin, Ovary

Publications for Spinal Cord Oligodendroglioma

Articles related to Spinal Cord Oligodendroglioma:

(showing 10, show less)
# Title Authors PMID Year
1
Primary Spinal Cord Oligodendroglioma with Postoperative Adjuvant Radiotherapy: A Case Report. 61
26512274 2015
2
Sudden death from diffuse leptomeningeal oligodendrogliomatosis. 61
21888480 2011
3
Spinal cord anaplastic oligodendroglioma with 1p deletion: report of a relapsing case treated with temozolomide. 61
21190059 2011
4
Spinal cord oligodendroglioma with 1p and 19q deletions presenting with cerebral oligodendrogliomatosis. 61
19558288 2009
5
Primary spinal cord oligodendroglioma. Case illustration. 61
17242843 2006
6
Primary spinal cord oligodendroglioma: case report and review of the literature. 61
15138790 2005
7
Oligodendroglioma in the cervical spinal cord of a dog. 61
15347828 2004
8
Mucinous oligodendroglioma of the spinal cord in a dog. 61
7820760 1995
9
[Oligodendroglioma of spinal cord]. 61
3046717 1988
10
Spinal cord oligodendroglioma. 61
6079205 1967

Variations for Spinal Cord Oligodendroglioma

Expression for Spinal Cord Oligodendroglioma

Search GEO for disease gene expression data for Spinal Cord Oligodendroglioma.

Pathways for Spinal Cord Oligodendroglioma

GO Terms for Spinal Cord Oligodendroglioma

Biological processes related to Spinal Cord Oligodendroglioma according to GeneCards Suite gene sharing:

(showing 12, show less)
# Name GO ID Score Top Affiliating Genes
1 response to oxidative stress GO:0006979 9.69 TP53 IDH1 EGFR
2 response to organic cyclic compound GO:0014070 9.67 MGMT IDH1 EGFR
3 wound healing GO:0042060 9.61 TP53 NF1 EGFR
4 2-oxoglutarate metabolic process GO:0006103 9.48 IDH2 IDH1
5 DNA damage response, signal transduction by p53 class mediator GO:0030330 9.46 TP53 ATRX
6 positive regulation of production of miRNAs involved in gene silencing by miRNA GO:1903800 9.4 TP53 EGFR
7 salivary gland morphogenesis GO:0007435 9.37 FGFR1 EGFR
8 NADP metabolic process GO:0006739 9.32 IDH2 IDH1
9 negative regulation of neuroblast proliferation GO:0007406 9.26 TP53 NF1
10 regulation of cell proliferation GO:0042127 9.26 TP53 NF1 FGFR1 EGFR
11 isocitrate metabolic process GO:0006102 9.16 IDH2 IDH1
12 glyoxylate cycle GO:0006097 8.62 IDH2 IDH1

Molecular functions related to Spinal Cord Oligodendroglioma according to GeneCards Suite gene sharing:

(showing 5, show less)
# Name GO ID Score Top Affiliating Genes
1 identical protein binding GO:0042802 9.8 TP53 SYP IDH1 GFAP FGFR1 EGFR
2 protein phosphatase binding GO:0019903 9.43 TP53 LGALS3 EGFR
3 SH2 domain binding GO:0042169 9.33 SYP LAX1 FGFR1
4 isocitrate dehydrogenase (NADP+) activity GO:0004450 8.96 IDH2 IDH1
5 isocitrate dehydrogenase activity GO:0004448 8.62 IDH2 IDH1

Sources for Spinal Cord Oligodendroglioma

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
17 EFO
18 ExPASy
19 FMA
28 GO
29 GTR
30 HMDB
31 HPO
32 ICD10
33 ICD10 via Orphanet
34 ICD9CM
35 IUPHAR
36 KEGG
37 LifeMap
39 LOVD
41 MedGen
43 MeSH
44 MESH via Orphanet
45 MGI
48 NCI
49 NCIt
50 NDF-RT
53 NINDS
54 Novoseek
56 OMIM
57 OMIM via Orphanet
61 PubMed
63 QIAGEN
68 SNOMED-CT via HPO
69 TGDB
70 Tocris
71 UMLS
72 UMLS via Orphanet
Content
Loading form....